New Optimism on Myelodysplastic Syndromes

Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment approaches for myelodysplastic syndromes (MDS), which are rare and often deadly bone…

Ramiro Garzon, MD, to Lead Hematologic Cancers at Huntsman Cancer Institute and University of Utah Health

A national authority in hematology will soon lead Hematology and Hematological Malignancies at Huntsman Cancer Institute and University of Utah Health. Dr. Ramiro Garzon’s focus is patients with leukemia and researching the molecular mechanisms of these cancers. Garzon’s major focuses include developing new treatment for cancers that begin in blood forming tissue such as the bone marrow or in the cells of the immune system. He explains his research and clinical goals.

NCCN Annual Congress on Hematologic Malignancies™ Returns to In-Person October 14–15, 2022 in New York City

The 2022 NCCN Annual Congress on Hematologic Malignancies™ (#NCCNhem22) is taking place Friday, October 14–Saturday, October 15, 2022 in New York City. All live sessions will also stream remotely through a virtual event platform.